Amanote Research
Register
Sign In
Matching Adjusted Indirect Comparison of Sunitinib and Everolimus for the Treatment of Pancreatic Neuroendocrine Tumours (PNETS)
Value in Health
- United Kingdom
doi 10.1016/j.jval.2017.08.141
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2017
Authors
J Ishak
M Rael
M Hicks
S Mittal
M Eatock
JW Valle
Publisher
Elsevier BV
Related search
An Overview on the Sequential Treatment of Pancreatic Neuroendocrine Tumors (pNETs)
Rare Cancers and Therapy
PCN16 Clinical Effectiveness Analysis of Sunitinib for the Treatment of Pancreatic Neuroendocrine Tumors
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Regional Lymphadenectomy Is Indicated in the Surgical Treatment of Pancreatic Neuroendocrine Tumors (PNETs)
Annals of Surgery
Surgery
Role of Sunitinib for the Management of Pancreatic Neuroendocrine Tumors
Gastrointestinal Cancer: Targets and Therapy
Matching-Adjusted Indirect Comparison of Benralizumab Versus Interleukin-5 Inhibitors: Systematic Review
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Prm236 - Calibrating Matching Adjusted Indirect Comparison Estimate to Real-World Population
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Sunitinib in Pancreatic Neuroendocrine Tumors. Clinical Case
Medical Council
Pcn37 - Matching-Adjusted Indirect Comparison of the Efficacy of Apalutamide and Enzalutamide in the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Comparative Efficacy of Combination Immunotherapy and Targeted Therapy in the Treatment of BRAF-mutant Advanced Melanoma: A Matching-Adjusted Indirect Comparison
Immunotherapy
Oncology
Allergy
Immunology
